Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes

被引:51
作者
Gimeno, R
Lee, CK
Schindler, C
Levy, DE
机构
[1] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA
[3] Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA
关键词
D O I
10.1128/MCB.25.13.5456-5465.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha/beta interferon (IFN-alpha/beta) triggers antiviral and antiproliferative responses in target cells through modulation of gene expression. The JAK-STAT pathway is the major mediator of these biological effects through the activation of the transcription factors STAT1 and STAT2, and gene ablation studies have demonstrated that both STAT1 and STAT2 are required for most antiviral responses induced by IFN-alpha/beta. However, additional signaling pathways are also activated by IFN. Here, we show that these additional pathways provoke a proliferative response in activated T lymphocytes. While activation of IFN-stimulated gene factor 3 produces a dominant inhibitory signal capable of overriding the mitogenic response, absence of either STAT1 or STAT2 leads to a proliferative response to IFN. Growth stimulation by IFN-alpha/beta is independent of other STAT proteins, particularly of STAT3, since T lymphocytes from STAT1-STAT3 double-knockout mice are growth stimulated by IFN-alpha/beta treatment. IFN-alpha/beta can cooperate with numerous T-cell mitogens, including interleukin-2 (IL-2), IL-4, IL-7, and IL-12, and can contribute to the rapid restoration of the thymus following glucocorticoid-mediated ablation. These results underscore the complexity of the cellular response to IFN and suggest that the ultimate outcome of IFN action results from a balance between growth-inhibitory and -stimulatory effects.
引用
收藏
页码:5456 / 5465
页数:10
相关论文
共 41 条
[1]   Interferons α and β as immune regulators -: A new look [J].
Biron, CA .
IMMUNITY, 2001, 14 (06) :661-664
[2]   Regulation and function of serine kinase networks in lymphocytes [J].
Cantrell, DA .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (03) :294-298
[3]   Mutational switch of an IL-6 response to an interferon-γ-like response [J].
Costa-Pereira, AP ;
Tininini, S ;
Strobl, B ;
Alonzi, T ;
Schlaak, JF ;
Is'harc, H ;
Gesualdo, I ;
Newman, SJ ;
Kerr, IM ;
Poli, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8043-8047
[4]   The immunobiology of cancer immunosurveillance and immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
IMMUNITY, 2004, 21 (02) :137-148
[5]   Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency [J].
Dupuis, S ;
Jouanguy, E ;
Al-Hajjar, S ;
Fieschi, C ;
Al-Mohsen, IZ ;
Al-Jumaah, S ;
Yang, K ;
Chapgier, A ;
Eidenschenk, C ;
Eid, P ;
Al Ghonaium, A ;
Tufenkeji, H ;
Frayha, H ;
Al-Gazlan, S ;
Al-Rayes, HA ;
Schreiber, RD ;
Gresser, I ;
Casanova, JL .
NATURE GENETICS, 2003, 33 (03) :388-391
[6]   Type IIFN modulates innate and specific antiviral immunity [J].
Durbin, JE ;
Fernandez-Sesma, A ;
Lee, CK ;
Rao, TD ;
Frey, AB ;
Moran, TM ;
Vukmanovic, S ;
García-Sastre, A ;
Levy, DE .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4220-4228
[7]   Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease [J].
Durbin, JE ;
Hackenmiller, R ;
Simon, MC ;
Levy, DE .
CELL, 1996, 84 (03) :443-450
[8]   Stat-1 is not essential for inhibition of B lymphopoiesis by type IIFNs [J].
Gongora, R ;
Stephan, RP ;
Schreiber, RD ;
Cooper, MD .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2362-2366
[9]  
Hatakeyama M, 1995, Prog Cell Cycle Res, V1, P9
[10]   Silencing STATs: lessons from paramyxovirus interferon evasion [J].
Horvath, CM .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (2-3) :117-127